ZYUS Life Sciences Corp, a prominent player in the health care sector, has been making significant strides in the capital markets with its innovative approach to phyto-therapeutics. Based in Saskatoon, Canada, the company is dedicated to advancing cannabinoid formulations as a standard of care, while also exploring the potential of protein-based formulations. As of November 27, 2025, ZYUS Life Sciences Corp’s close price stood at 0.65 CAD, reflecting a dynamic market presence on the TSX Venture Exchange.
The company’s market capitalization is currently valued at 52,050,000 CAD, showcasing its substantial footprint in the health care industry. Despite a challenging financial landscape, as indicated by a price-to-earnings ratio of -1.45, ZYUS Life Sciences Corp continues to focus on long-term growth and innovation. This strategic focus is evident in their commitment to developing cutting-edge therapeutic solutions that cater to a global customer base.
Over the past year, ZYUS Life Sciences Corp has experienced fluctuations in its stock price, with a 52-week high of 0.95 CAD on December 2, 2024, and a low of 0.55 CAD on May 19, 2025. These variations underscore the volatile nature of the capital markets and the company’s resilience in navigating these challenges.
ZYUS Life Sciences Corp’s dedication to phyto-therapeutics is particularly noteworthy. By concentrating on cannabinoid formulations, the company aims to redefine treatment standards and offer novel solutions to patients worldwide. This focus not only highlights their commitment to innovation but also positions them as a leader in the burgeoning field of cannabinoid research.
In addition to their work with cannabinoids, ZYUS Life Sciences Corp is actively exploring protein-based formulations. This dual approach underscores their comprehensive strategy to address diverse therapeutic needs and expand their portfolio of health care solutions.
As ZYUS Life Sciences Corp continues to evolve, their global reach and commitment to excellence remain central to their mission. For more detailed information on their activities and developments, stakeholders and interested parties are encouraged to visit their website at www.zyus.com .
In summary, ZYUS Life Sciences Corp stands at the forefront of the health care sector, driven by a vision to innovate and lead in the field of phyto-therapeutics. Their strategic initiatives and global presence position them well for future growth and success in the capital markets.
